Originally published on Fri October 5, 2012 3:24 pm
The news that the cost of personal genome sequencing will soon drop as low as $1,000 has generated a quite a bit of interest and concern — from medical researchers, biotech companies, bioethicists and the average consumer alike.
NPR's Rob Stein explored many of the implications of this technology in his four-part series "The $1,000 Genome." They're complicated, to say the least.
Originally published on Fri October 5, 2012 2:25 pm
By Michaeleen Doucleff
The Ebola outbreak in Uganda, which started two months ago, has come to a close.
"The Ministry of Health [of Uganda] has been very prudent of declaring the outbreak over," Gregory Hartl, a World Health Organization spokesman, tells Shots. The last case was detected over 42 days ago — or twice the incubation period for the hemorrhagic fever — so new infections are highly unlikely.